Clinical trial design is evolving in the ALS/MND community. This webinar updates us on what the new models are, how they are changing the landscape and what are the practical implications for our community.
Moderators:
Gethin Thomas – Executive Director, Research | Motor Neurone Disease Australia
Claire Magnussen, PhD – Program Manager, CAPTURE ALS, McGill University
Panel:
Dr. Merit Cudkowicz – HEALEY Trial
Dr. Ruben van Eijk – MAGNET Trial
Dr Suvankar Pal & Professor Siddharthan Chandran – SMART Trial